|
US5994392A
(en)
|
1988-02-26 |
1999-11-30 |
Neuromedica, Inc. |
Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
|
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
|
US20030073642A1
(en)
*
|
1993-02-22 |
2003-04-17 |
American Bioscience, Inc. |
Methods and formulations for delivery of pharmacologically active agents
|
|
US5972948A
(en)
*
|
1994-07-01 |
1999-10-26 |
Solvay Pharmaceuticals Gmbh |
Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
|
|
US6231888B1
(en)
|
1996-01-18 |
2001-05-15 |
Perio Products Ltd. |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
|
|
US6576636B2
(en)
*
|
1996-05-22 |
2003-06-10 |
Protarga, Inc. |
Method of treating a liver disorder with fatty acid-antiviral agent conjugates
|
|
US5795909A
(en)
*
|
1996-05-22 |
1998-08-18 |
Neuromedica, Inc. |
DHA-pharmaceutical agent conjugates of taxanes
|
|
ATE196844T1
(de)
*
|
1996-05-22 |
2000-10-15 |
Protarga Inc |
Zusammensetzungen die konjugate von cis- docosahexaenoic-säure und taxotere enthalten
|
|
KR100330373B1
(ko)
*
|
1996-05-28 |
2002-11-07 |
주식회사한국신약 |
탁솔을 함유한 주사용 약제 조성물
|
|
US6440980B1
(en)
*
|
1996-09-17 |
2002-08-27 |
Avanir Pharmaceuticals |
Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
|
|
CA2291074C
(en)
*
|
1997-05-21 |
2008-04-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Composition and method for enhancing transport across biological membranes
|
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
|
ZA986614B
(en)
*
|
1997-07-25 |
1999-01-27 |
Gilead Sciences |
Nucleotide analog composition
|
|
US6426369B1
(en)
*
|
1997-09-17 |
2002-07-30 |
Eisai Co., Ltd. |
Oxethazaine as antimicrobial agent
|
|
US20030077227A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US20090162300A1
(en)
*
|
1997-10-01 |
2009-06-25 |
Dugger Iii Harry A |
Buccal, polar and non-polar spray containing alprazolam
|
|
US20030095926A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
|
|
US7632517B2
(en)
*
|
1997-10-01 |
2009-12-15 |
Novadel Pharma Inc. |
Buccal, polar and non-polar spray containing zolpidem
|
|
US20050163719A1
(en)
*
|
1997-10-01 |
2005-07-28 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing diazepam
|
|
US20030077229A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
|
|
US20030095925A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
|
|
US20030077228A1
(en)
*
|
1997-10-01 |
2003-04-24 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
|
|
US20030190286A1
(en)
*
|
1997-10-01 |
2003-10-09 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
|
|
US20030095927A1
(en)
*
|
1997-10-01 |
2003-05-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
|
|
US20030185761A1
(en)
*
|
1997-10-01 |
2003-10-02 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
|
US20040141923A1
(en)
*
|
1997-10-01 |
2004-07-22 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing alprazolam
|
|
US20040136914A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing ondansetron
|
|
US20050287075A1
(en)
*
|
1997-10-01 |
2005-12-29 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating pain
|
|
US20030082107A1
(en)
*
|
1997-10-01 |
2003-05-01 |
Dugger Harry A. |
Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
|
|
US20040136915A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing atropine
|
|
US20050281752A1
(en)
*
|
1997-10-01 |
2005-12-22 |
Dugger Harry A Iii |
Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
|
|
US20040136913A1
(en)
*
|
1997-10-01 |
2004-07-15 |
Dugger Harry A. |
Buccal, polar and non-polar spray containing sumatriptan
|
|
US20050180923A1
(en)
*
|
1997-10-01 |
2005-08-18 |
Dugger Harry A.Iii |
Buccal, polar and non-polar spray containing testosterone
|
|
DE69738333T2
(de)
*
|
1997-10-01 |
2008-11-27 |
Novadel Pharma Inc. |
Nichtpolares Spray zur bukkalen Verabreichung
|
|
US20050002867A1
(en)
*
|
1997-10-01 |
2005-01-06 |
Novadel Pharma Inc. |
Buccal, polar and non-polar sprays containing propofol
|
|
US5977174A
(en)
*
|
1997-11-26 |
1999-11-02 |
Neuromedica, Inc. |
Cholinergic compositions and uses thereof
|
|
US6197764B1
(en)
|
1997-11-26 |
2001-03-06 |
Protarga, Inc. |
Clozapine compositions and uses thereof
|
|
US6153653A
(en)
*
|
1997-11-26 |
2000-11-28 |
Protarga, Inc. |
Choline compositions and uses thereof
|
|
US5955459A
(en)
*
|
1997-11-26 |
1999-09-21 |
Neuromedica, Inc. |
Fatty acid-antipsychotic compositions and uses thereof
|
|
KR20000076105A
(ko)
*
|
1998-01-13 |
2000-12-26 |
도리이 신이찌로 |
항생제를 함유한 국소 투여용 항균 조성물
|
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
UA65607C2
(uk)
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
|
FI980901A7
(fi)
*
|
1998-04-23 |
1999-10-24 |
Orion Yhtymae Oyj |
Levosimendaania säädellysti vapauttavia oraalisia koostumuksia
|
|
ES2559766T3
(es)
*
|
1998-05-18 |
2016-02-15 |
Takeda Pharmaceutical Company Limited |
Comprimidos disgregables en la boca
|
|
US7413759B2
(en)
*
|
1998-05-21 |
2008-08-19 |
Beech-Nut Nutrition Corporation |
Method of enhancing cognitive ability in infant fed DHA containing baby-food compositions
|
|
BR9912145A
(pt)
*
|
1998-07-20 |
2001-09-25 |
Smithkline Beecham Corp |
Formulações bioaperfeiçoadas contendo eprosartan em forma de dosagem sólida oral
|
|
AU4802099A
(en)
*
|
1998-07-28 |
2000-02-21 |
Takeda Chemical Industries Ltd. |
Rapidly disintegrable solid preparation
|
|
EP1110553B1
(en)
*
|
1998-08-10 |
2013-03-27 |
Asahi Kasei Pharma Corporation |
Sustained release oral preparations of fasudil hydrochloride
|
|
US8236352B2
(en)
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
EP2266542A3
(en)
*
|
1998-10-01 |
2013-07-31 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
|
US6652864B1
(en)
|
1998-12-21 |
2003-11-25 |
Asilomar Pharmaceuticals, Inc. |
Compounds for intracellular delivery of therapeutic moieties to nerve cells
|
|
EP1147879B8
(en)
*
|
1999-01-29 |
2008-12-24 |
Takeda Pharmaceutical Company Limited |
Compressing mallet with coating treatment
|
|
US7235583B1
(en)
|
1999-03-09 |
2007-06-26 |
Luitpold Pharmaceuticals, Inc., |
Fatty acid-anticancer conjugates and uses thereof
|
|
KR20020000147A
(ko)
*
|
1999-03-09 |
2002-01-04 |
니겔 엘. 웹 |
지방산-항암제 결합체 및 그의 용도
|
|
US6475984B2
(en)
*
|
1999-04-29 |
2002-11-05 |
The Nemours Foundation |
Administration of leptin
|
|
EP1175217B8
(en)
*
|
1999-05-07 |
2009-03-18 |
Wockhardt Limited |
(s)-benzoquinolizine carboxylic acids and their use as antibacterial agents
|
|
WO2000067802A1
(en)
*
|
1999-05-10 |
2000-11-16 |
Protarga, Inc. |
Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
|
|
US6197337B1
(en)
*
|
1999-05-10 |
2001-03-06 |
Kenneth Weisman |
Therapeutic uses of abarelix
|
|
US7175855B1
(en)
*
|
1999-05-27 |
2007-02-13 |
Pfizer Inc. |
Ziprasidone suspension
|
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
|
US7229961B2
(en)
*
|
1999-08-24 |
2007-06-12 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into ocular tissues
|
|
US6669951B2
(en)
|
1999-08-24 |
2003-12-30 |
Cellgate, Inc. |
Compositions and methods for enhancing drug delivery across and into epithelial tissues
|
|
JP2003507438A
(ja)
|
1999-08-24 |
2003-02-25 |
セルゲイト， インコーポレイテッド |
オリゴアルギニン部分を使用する上皮組織を横切るおよび上皮組織内への薬物送達の増強
|
|
US6730293B1
(en)
|
1999-08-24 |
2004-05-04 |
Cellgate, Inc. |
Compositions and methods for treating inflammatory diseases of the skin
|
|
WO2001017524A1
(en)
*
|
1999-09-09 |
2001-03-15 |
Efa Sciences Llc. |
Methods for treating cell proliferative disorders including cancer
|
|
US6426367B1
(en)
*
|
1999-09-09 |
2002-07-30 |
Efa Sciences Llc |
Methods for selectively occluding blood supplies to neoplasias
|
|
US6380405B1
(en)
|
1999-09-13 |
2002-04-30 |
Nobex Corporation |
Taxane prodrugs
|
|
US6541508B2
(en)
*
|
1999-09-13 |
2003-04-01 |
Nobex Corporation |
Taxane prodrugs
|
|
US6713454B1
(en)
|
1999-09-13 |
2004-03-30 |
Nobex Corporation |
Prodrugs of etoposide and etoposide analogs
|
|
AU775373B2
(en)
|
1999-10-01 |
2004-07-29 |
Immunogen, Inc. |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
|
|
US6383511B1
(en)
*
|
1999-10-25 |
2002-05-07 |
Epicept Corporation |
Local prevention or amelioration of pain from surgically closed wounds
|
|
CA2391502A1
(en)
*
|
1999-11-15 |
2001-05-25 |
Pharma Mar S.A |
Aplidine treatment of cancers
|
|
WO2001040177A2
(en)
*
|
1999-12-02 |
2001-06-07 |
Women And Infants Hospital |
Esters of vitamin d3 and uses thereof
|
|
US6638906B1
(en)
|
1999-12-13 |
2003-10-28 |
Nobex Corporation |
Amphiphilic polymers and polypeptide conjugates comprising same
|
|
US6380253B1
(en)
*
|
2000-01-05 |
2002-04-30 |
Efa Sciences Llc |
Method of stabilizing and potentiating the action of anti-angiogenic substances
|
|
AU2001230994A1
(en)
|
2000-01-19 |
2001-07-31 |
The United States of America, represented by The Secretary, Department of Health & Human Services |
Use of pentosan polysulfate to treat certain conditions of the prostate
|
|
CO5280224A1
(es)
*
|
2000-02-02 |
2003-05-30 |
Univ Florida State Res Found |
Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
|
|
BR0104354A
(pt)
*
|
2000-02-02 |
2002-01-02 |
Univ Florida State Res Found |
Taxanos substituìdos com éster c10
|
|
US6649632B2
(en)
|
2000-02-02 |
2003-11-18 |
Fsu Research Foundation, Inc. |
C10 ester substituted taxanes
|
|
US6730691B1
(en)
|
2000-02-10 |
2004-05-04 |
Miles A. Galin |
Uses of alpha adrenergic blocking agents
|
|
US6660750B2
(en)
|
2000-02-15 |
2003-12-09 |
University Of Iowa Research Foundation |
Flavopiridol methods and compositions for HIV therapy
|
|
US6452024B1
(en)
|
2000-02-22 |
2002-09-17 |
Chaichem Pharmaceuticals International |
Process for extraction and purification of paclitaxel from natural sources
|
|
US20030083342A1
(en)
*
|
2002-08-27 |
2003-05-01 |
Steele Ronald Edward |
Combination of organic compounds
|
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
|
US6392055B1
(en)
|
2000-07-19 |
2002-05-21 |
The University Of Pittsburgh |
Synthesis and biological evaluation of analogs of the antimitotic marine natural product curacin A
|
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
|
US6884777B1
(en)
|
2000-11-14 |
2005-04-26 |
The Nemours Foundation |
Method for treating respiratory distress syndrome
|
|
JP2005500988A
(ja)
*
|
2001-03-23 |
2005-01-13 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪族アミン薬物複合体
|
|
JP4634694B2
(ja)
*
|
2001-03-23 |
2011-02-16 |
ルイトポルド・ファーマシューティカルズ・インコーポレーテッド |
脂肪アルコール薬物複合体
|
|
US20020198228A1
(en)
*
|
2001-04-03 |
2002-12-26 |
Kaura Sita R. |
Composition and method for the treatment of respiratory desease
|
|
WO2002089853A2
(en)
*
|
2001-05-03 |
2002-11-14 |
Allergan, Inc. |
Compositions having enhanced pharmacokinetic characteristics
|
|
US20020198209A1
(en)
*
|
2001-05-03 |
2002-12-26 |
Allergan Sales Inc. |
Compositions having enhanced pharmacokinetic characteristics
|
|
US7425565B2
(en)
*
|
2002-05-09 |
2008-09-16 |
Cedars-Sinai Medical Center |
Use of benzothiopenes to treat and prevent prostate cancer
|
|
CA2354486A1
(en)
*
|
2001-07-31 |
2003-01-31 |
Florida State University Research Foundation, Inc. |
C7 ester substituted taxanes
|
|
CA2354471A1
(en)
*
|
2001-07-31 |
2003-01-31 |
Florida State University Research Foundation, Inc. |
C10 ester substituted taxanes
|
|
SG129990A1
(en)
*
|
2001-08-01 |
2007-03-20 |
Univ Florida State Res Found |
C10 ester substituted taxanes
|
|
SG125889A1
(en)
*
|
2001-08-01 |
2006-10-30 |
Univ Florida State Res Found |
C7 ester subsituted taxanes
|
|
US6852737B2
(en)
*
|
2001-08-06 |
2005-02-08 |
Recordati Ireland Limited |
Crude and crystalline forms of lercanidipine hydrochloride
|
|
ES2399977T3
(es)
*
|
2001-09-27 |
2013-04-04 |
Ramot At Tel Aviv University Ltd. |
Conjugado de perfenazina o flufenazina con ácidos carboxílicos
|
|
AU2004201240B2
(en)
*
|
2001-09-27 |
2008-08-07 |
Bar Ilan University |
Conjugated Psychotropic Drugs and Uses Thereof
|
|
US7544681B2
(en)
*
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
|
US6730667B2
(en)
*
|
2001-11-26 |
2004-05-04 |
William R. Deagle |
Iontophoresis disc pain blocker
|
|
AU2002352982B2
(en)
*
|
2001-11-29 |
2008-03-06 |
Sound Pharmaceuticals Incorporated |
Methods and compositions for ameliorating the undesirable effects of chemotherapy
|
|
ES2497716T3
(es)
*
|
2002-01-04 |
2014-09-23 |
Sound Pharmaceuticals Incorporated |
Composiciones para utilizar en métodos destinados a tratar la pérdida auditiva
|
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
|
CA2475092C
(en)
|
2002-02-04 |
2012-05-01 |
Christian F. Wertz |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
|
JP2005525368A
(ja)
*
|
2002-03-04 |
2005-08-25 |
メディミューン，インコーポレーテッド |
インテグリンαｖβ３アンタゴニストをＨＭＧ−ＣｏＡ還元酵素阻害剤またはビスフォスフォネートと併用投与する障害の予防または治療方法
|
|
JPWO2003094917A1
(ja)
*
|
2002-05-13 |
2005-09-08 |
高田製薬株式会社 |
ビントペロール含有経皮投与用医薬組成物
|
|
US20040266776A1
(en)
*
|
2003-06-25 |
2004-12-30 |
Gil Daniel W. |
Methods of preventing and reducing the severity of stress-associated conditions
|
|
US20040002663A1
(en)
*
|
2002-06-26 |
2004-01-01 |
Reeves William H. |
Method and system for use in detecting a cancerous and precancerous pathology
|
|
CA2492488A1
(en)
*
|
2002-07-16 |
2004-01-22 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
|
US7273889B2
(en)
*
|
2002-09-25 |
2007-09-25 |
Innovative Drug Delivery Systems, Inc. |
NMDA receptor antagonist formulation with reduced neurotoxicity
|
|
US20040235811A1
(en)
*
|
2002-10-08 |
2004-11-25 |
Sepracor Inc. |
Fatty acid modified forms of glucocorticoids
|
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
|
BR0316776A
(pt)
*
|
2002-12-10 |
2005-10-25 |
Biosynexus Inc |
Formula para anti-infeccioso tópico
|
|
US7524515B2
(en)
*
|
2003-01-10 |
2009-04-28 |
Mutual Pharmaceuticals, Inc. |
Pharmaceutical safety dosage forms
|
|
EP1583539A2
(en)
*
|
2003-01-13 |
2005-10-12 |
Cedars-Sinai Medical Center |
Paricalcitol as a chemotherapeutic agent
|
|
US6759539B1
(en)
|
2003-02-27 |
2004-07-06 |
Chaichem Pharmaceuticals International |
Process for isolation and purification of paclitaxel from natural sources
|
|
US8912174B2
(en)
*
|
2003-04-16 |
2014-12-16 |
Mylan Pharmaceuticals Inc. |
Formulations and methods for treating rhinosinusitis
|
|
US9808471B2
(en)
*
|
2003-04-16 |
2017-11-07 |
Mylan Specialty Lp |
Nasal pharmaceutical formulations and methods of using the same
|
|
US7811606B2
(en)
*
|
2003-04-16 |
2010-10-12 |
Dey, L.P. |
Nasal pharmaceutical formulations and methods of using the same
|
|
CN1777439A
(zh)
*
|
2003-04-22 |
2006-05-24 |
研究及应用科学协会股份有限公司 |
生长抑素的载体
|
|
CA2523083C
(en)
|
2003-04-25 |
2014-07-08 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
|
EP1636335B1
(en)
*
|
2003-05-28 |
2012-07-11 |
Mito Tek, LLC |
Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
|
|
WO2005009446A1
(en)
*
|
2003-07-17 |
2005-02-03 |
Cotherix, Inc. |
Combination therapies for treatment of hypertension and complications in patients with diabetes or metabolic syndrome
|
|
US20060089374A1
(en)
*
|
2003-07-17 |
2006-04-27 |
Glenn Cornett |
Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
|
|
US20050187278A1
(en)
*
|
2003-08-28 |
2005-08-25 |
Pharmacia Corporation |
Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
|
|
WO2005021039A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Cotherix, Inc. |
Combination of cicletanine and an oral antidiabetic and/or blood lipid-lowering agent for treating diabetes and metabolic syndrome
|
|
US20050148534A1
(en)
*
|
2003-09-22 |
2005-07-07 |
Castellino Angelo J. |
Small molecule compositions and methods for increasing drug efficiency using compositions thereof
|
|
GB0322994D0
(en)
*
|
2003-10-01 |
2003-11-05 |
Novartis Ag |
Organic compounds
|
|
DE602004027936D1
(de)
*
|
2003-10-29 |
2010-08-12 |
Sonus Pharmaceutical Inc |
Tocopherolmodifizierte therapeutische arzneimittelverbindung
|
|
US20080045559A1
(en)
*
|
2003-10-29 |
2008-02-21 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
CA2544128A1
(en)
*
|
2003-10-30 |
2005-05-12 |
The Research Foundation Of State University Of New York |
Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
|
|
GB0326180D0
(en)
*
|
2003-11-11 |
2003-12-17 |
Leuven K U Res & Dev |
Biocompatible coating of medical devices
|
|
PE20050693A1
(es)
|
2004-02-13 |
2005-09-27 |
Univ Florida State Res Found |
Taxanos sustituidos con esteres de ciclopentilo en c10
|
|
US7160919B2
(en)
|
2004-03-05 |
2007-01-09 |
Florida State University Research Foundation, Inc. |
C7 lactyloxy-substituted taxanes
|
|
US20100028339A1
(en)
|
2004-03-29 |
2010-02-04 |
Cheng Jin Q |
Compositions including triciribine and trastuzumab and methods of use thereof
|
|
US20100009928A1
(en)
|
2004-03-29 |
2010-01-14 |
Cheng Jin Q |
Compositions including triciribine and taxanes and methods of use thereof
|
|
US20100009929A1
(en)
|
2004-03-29 |
2010-01-14 |
Cheng Jin Q |
Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof
|
|
EP1737472B1
(en)
|
2004-03-29 |
2014-08-13 |
University Of South Florida |
Effective treatment of tumors and cancer with triciribine
|
|
US20110008327A1
(en)
*
|
2004-03-29 |
2011-01-13 |
Cheng Jin Q |
Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
|
|
US20100173864A1
(en)
|
2004-03-29 |
2010-07-08 |
Cheng Jin Q |
Compositions including triciribine and one or more platinum compounds and methods of use thereof
|
|
GB0413729D0
(en)
*
|
2004-06-18 |
2004-07-21 |
Tillotts Pharma Ag |
A pharmaceutical composition and its use
|
|
GB0413730D0
(en)
*
|
2004-06-18 |
2004-07-21 |
Tillotts Pharma Ag |
A pharmaceutical composition and its use
|
|
JP2008508291A
(ja)
|
2004-07-27 |
2008-03-21 |
ギリアード サイエンシーズ， インコーポレイテッド |
抗ｈｉｖ剤としてのヌクレオシドホスホネート結合体
|
|
US20060154959A1
(en)
*
|
2005-01-13 |
2006-07-13 |
Navitas Pharma |
Combination therapies of cicletanine and carvedilol
|
|
US9132135B2
(en)
*
|
2004-09-24 |
2015-09-15 |
University Of Maryland, Baltimore |
Method of treating organophosphorous poisoning
|
|
EP2813225B1
(en)
*
|
2004-09-24 |
2017-12-13 |
University of Maryland, Baltimore |
Method of treating organophosphorous poisoning
|
|
US20060122127A1
(en)
*
|
2004-11-17 |
2006-06-08 |
Cypress Bioscience, Inc. |
Methods for reducing the side effects associated with mirtzapine treatment
|
|
US20070141174A1
(en)
*
|
2005-01-13 |
2007-06-21 |
Navitas Pharma, Inc. |
Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
|
|
US20080096915A1
(en)
*
|
2005-01-13 |
2008-04-24 |
Greenberg Traurig LLP |
Compositions for the treatment of metabolic disorders
|
|
CA2596755C
(en)
|
2005-02-09 |
2014-09-09 |
Paul Q. Anziano |
Compositions and methods for inhibiting an isoform of human manganese superoxide dismutase
|
|
WO2006096759A2
(en)
*
|
2005-03-08 |
2006-09-14 |
Sound Pharmaceuticals Incorporated |
Methods and compositions for treating cancer
|
|
US20060216767A1
(en)
*
|
2005-03-22 |
2006-09-28 |
Saladax Biomedical Inc. |
Docetaxel immunoassay
|
|
JP5337479B2
(ja)
|
2005-05-04 |
2013-11-06 |
プロノヴァ・バイオファーマ・ノルゲ・アーエス |
新規化合物
|
|
ES2400772T3
(es)
*
|
2005-06-07 |
2013-04-12 |
Ramot At Tel Aviv University Ltd. |
Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas
|
|
US20070105817A1
(en)
*
|
2005-11-09 |
2007-05-10 |
Jim Page |
Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
|
|
CN1870631B
(zh)
*
|
2005-11-11 |
2010-04-14 |
华为技术有限公司 |
媒体网关的门控方法
|
|
CA2635496A1
(en)
*
|
2005-11-14 |
2007-05-24 |
Peter D. Winch |
Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts
|
|
CA2632149C
(en)
*
|
2005-12-01 |
2011-11-15 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
DK3184526T3
(en)
*
|
2005-12-13 |
2019-01-14 |
Incyte Holdings Corp |
PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
|
|
CZ300305B6
(cs)
*
|
2005-12-20 |
2009-04-15 |
Heaton, A. S. |
Farmaceutická kompozice obsahující derivát taxanu se zlepšenou terapeutickou úcinností
|
|
WO2007119214A2
(en)
*
|
2006-04-13 |
2007-10-25 |
Actelion Pharmaceuticals Ltd |
Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
|
|
WO2007123955A2
(en)
*
|
2006-04-19 |
2007-11-01 |
Novadel Pharma Inc. |
Stable hydroalcoholic oral spray formulations and methods
|
|
ES2377467T3
(es)
*
|
2006-05-16 |
2012-03-27 |
Gilead Sciences, Inc. |
Procedimiento y composiciones para tratar enfermedades hematológicas malignas
|
|
FR2902659A1
(fr)
|
2006-06-23 |
2007-12-28 |
Pierre Fabre Medicament Sa |
Ester de dha et son utilisation dans le traitement et la prevention des maladies cardiovasculaires
|
|
CN101511388B
(zh)
|
2006-07-17 |
2012-10-24 |
特拉维夫大学拉莫特有限公司 |
含有精神药物或gaba激动剂和有机酸的缀合物以及它们在治疗疼痛和其它cns疾病中的用途
|
|
US20080248135A1
(en)
*
|
2006-07-28 |
2008-10-09 |
Collegium Pharmaceutical, Inc. |
Combination Therapy for Otitis with Antiseptic and pH Adjustment
|
|
WO2008021242A2
(en)
*
|
2006-08-10 |
2008-02-21 |
The Research Foundation Of State University Of New York |
Fluorotaxoid-fatty acid conjugates and pharmaceutical compositions thereof
|
|
US20080051380A1
(en)
|
2006-08-25 |
2008-02-28 |
Auerbach Alan H |
Methods and compositions for treating cancer
|
|
EP2094640A4
(en)
|
2006-11-01 |
2015-05-20 |
Pronova Biopharma Norge As |
ALPHA-SUBSTITUTED OMEGA-3 LIPIDS WHICH ARE ACTIVATORS OR MODULATORS OF THE PEROXISOMPROLIPATOR ACTOR-ACTIVATED RECEPTOR (PPAR)
|
|
NZ577716A
(en)
*
|
2006-12-21 |
2012-10-26 |
Pfizer Prod Inc |
Succinate salt of 2-((4-(1-methyl-4-(pyridin-4-yl)-1h-pyrazol-3-yl) phenoxy)methyl)quinoline
|
|
EP2124897A4
(en)
*
|
2006-12-22 |
2012-05-09 |
Novadel Pharma Inc |
SPRAYING, ORAL, STABLE, SPRAY PREPARATIONS AND ASSOCIATED METHODS
|
|
US20080312241A1
(en)
*
|
2007-01-03 |
2008-12-18 |
Gilead Sciences, Inc. |
Cicletanine and PKC inhibitors in the treatment of pulmonary and cardiac disorders
|
|
TWI384986B
(zh)
*
|
2007-01-17 |
2013-02-11 |
Lg Life Sciences Ltd |
抗病毒劑之順丁烯二酸單鹽以及含有該單鹽之醫藥組成物
|
|
JP2010520879A
(ja)
*
|
2007-03-09 |
2010-06-17 |
ノバルティス アーゲー |
３−（１ｈ−インドール−３−イル）−４−［２−（４−メチル−ピペラジン−１−イル）−キナゾリン−４−イル］−ピロール−２，５−ジオンの塩
|
|
US9220837B2
(en)
*
|
2007-03-19 |
2015-12-29 |
Insuline Medical Ltd. |
Method and device for drug delivery
|
|
AU2008251370A1
(en)
*
|
2007-05-10 |
2008-11-20 |
Novadel Pharma Inc. |
Anti-insomnia compositions and methods
|
|
WO2008150845A1
(en)
*
|
2007-05-31 |
2008-12-11 |
Vanderbilt University |
Screening for wnt pathway modulators and pyrvinium for the treatment of cance
|
|
DK2740731T3
(en)
*
|
2007-06-13 |
2016-04-11 |
Incyte Holdings Corp |
CRYSTALLINE SALTS OF JANUSKINASEINHIBITOREN (R) -3- (4- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-CYCLOPENTYLPROPANNITRIL
|
|
US8067632B2
(en)
*
|
2007-07-26 |
2011-11-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Process to produce prostratin and structural or functional analogs thereof
|
|
US8399420B2
(en)
*
|
2007-09-26 |
2013-03-19 |
Mount Sanai School of Medicine |
Azacytidine analogues and uses thereof
|
|
US7985325B2
(en)
*
|
2007-10-30 |
2011-07-26 |
Novellus Systems, Inc. |
Closed contact electroplating cup assembly
|
|
EP2220098A2
(en)
*
|
2007-12-12 |
2010-08-25 |
Ultimorphix Technologies B.v. |
Solid forms of tenofovir disoproxil
|
|
PE20091156A1
(es)
*
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
|
EP2252578B1
(en)
|
2008-02-11 |
2012-08-01 |
Ramot at Tel Aviv University Ltd. |
Conjugates for treating neurodegenerative diseases and disorders
|
|
EP2276755A4
(en)
|
2008-03-31 |
2011-05-04 |
Univ Florida State Res Found |
C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES
|
|
MX2010011165A
(es)
*
|
2008-04-10 |
2011-02-22 |
Abraxis Bioscience Llc |
Composiciones de derivados de taxano hidrofobos y sus usos.
|
|
ES2444128T3
(es)
*
|
2008-05-13 |
2014-02-24 |
Astrazeneca Ab |
Nueva SAL-554
|
|
US8835506B2
(en)
|
2008-06-05 |
2014-09-16 |
Stc.Unm |
Methods and related compositions for the treatment of cancer
|
|
HRP20180107T1
(hr)
|
2008-07-08 |
2018-03-09 |
Catabasis Pharmaceuticals, Inc. |
Acetilirani salicilati masnih kiselina i njihova upotreba
|
|
EP2307435B1
(en)
|
2008-07-08 |
2012-06-13 |
Gilead Sciences, Inc. |
Salts of hiv inhibitor compounds
|
|
US9085527B2
(en)
|
2008-07-08 |
2015-07-21 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid acylated salicylates and their uses
|
|
CA2742366C
(en)
*
|
2008-12-01 |
2020-09-22 |
Targacept, Inc. |
Synthesis and salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidine
|
|
US9145396B2
(en)
|
2008-12-01 |
2015-09-29 |
Targacept, Inc. |
Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
|
|
JP2012512165A
(ja)
*
|
2008-12-11 |
2012-05-31 |
バイオヴィスタ，インコーポレイテッド |
四環系ピラジノインドールを用いた多発性硬化症の治療方法
|
|
KR20170062554A
(ko)
*
|
2008-12-18 |
2017-06-07 |
노파르티스 아게 |
1-［4-［1-(4-시클로헥실-3-트리플루오로메틸-벤질옥시이미노)-에틸］-2-에틸-벤질］-아제티딘-3-카르복실산의 헤미푸마레이트 염
|
|
US9034389B2
(en)
|
2009-03-11 |
2015-05-19 |
Stable Solutions Llc |
Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
|
|
US8993625B2
(en)
*
|
2009-03-11 |
2015-03-31 |
Stable Solutions Llc |
Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
|
|
BRPI1014160A2
(pt)
*
|
2009-04-10 |
2015-08-25 |
Abraxis Bioscience Llc |
Formulações de nanopartículas e aplicações das mesmas
|
|
EP2433124B1
(en)
*
|
2009-05-19 |
2017-03-01 |
Vivia Biotech S.L. |
Methods for providing personalized medicine tests ex vivo for hematological neoplasms
|
|
AU2010249443B2
(en)
|
2009-05-22 |
2015-08-13 |
Incyte Holdings Corporation |
3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]octane- or heptane-nitrile as JAK inhibitors
|
|
TW201113285A
(en)
*
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
AU2010329440A1
(en)
|
2009-12-09 |
2012-08-09 |
Bar-Ilan University |
Methods of improving cognitive functions
|
|
SG182414A1
(en)
*
|
2010-01-08 |
2012-08-30 |
Catabasis Pharmaceuticals Inc |
Fatty acid fumarate derivatives and their uses
|
|
AU2011224484A1
(en)
|
2010-03-10 |
2012-09-27 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
|
|
MY161078A
(en)
|
2010-05-21 |
2017-04-14 |
Incyte Holdings Corp |
Topical formulation for a jak inhibitor
|
|
US8916610B2
(en)
|
2010-09-22 |
2014-12-23 |
Ramot At Tel-Aviv University Ltd. |
Acid addition salt of a nortriptyline-GABA conjugate and a process of preparing same
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
EP2640723A1
(en)
|
2010-11-19 |
2013-09-25 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
US20120178813A1
(en)
|
2011-01-12 |
2012-07-12 |
Thetis Pharmaceuticals Llc |
Lipid-lowering antidiabetic agent
|
|
WO2012154554A1
(en)
*
|
2011-05-06 |
2012-11-15 |
Catabasis Pharmaceuticals, Inc. |
Fatty acid triterpene derivatives and their uses
|
|
KR20140040819A
(ko)
|
2011-06-20 |
2014-04-03 |
인사이트 코포레이션 |
Ｊａｋ 저해제로서의 아제티디닐 페닐, 피리딜 또는 피라지닐 카르복스아미드 유도체
|
|
CN102952138B
(zh)
*
|
2011-08-17 |
2016-07-06 |
上海特化医药科技有限公司 |
一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
EP2915525B1
(en)
|
2011-09-19 |
2021-08-11 |
Orexo AB |
Sublingual abuse-resistant tablets comprising buprenorphine and naloxone
|
|
EP2847158A4
(en)
*
|
2012-05-07 |
2015-12-30 |
Cellix Bio Private Ltd |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS AND NEURODEGENERATIVE DISORDERS
|
|
WO2013173720A1
(en)
|
2012-05-18 |
2013-11-21 |
Incyte Corporation |
Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
US9382187B2
(en)
|
2012-07-10 |
2016-07-05 |
Thetis Pharmaceuticals Llc |
Tri-salt form of metformin
|
|
US8765811B2
(en)
|
2012-07-10 |
2014-07-01 |
Thetis Pharmaceuticals Llc |
Tri-salt form of metformin
|
|
PH12020551186B1
(en)
|
2012-11-15 |
2024-03-20 |
Incyte Holdings Corp |
Sustained-release dosage forms of ruxolitinib
|
|
JP6397831B2
(ja)
|
2013-03-06 |
2018-09-26 |
インサイト・ホールディングス・コーポレイションＩｎｃｙｔｅ Ｈｏｌｄｉｎｇｓ Ｃｏｒｐｏｒａｔｉｏｎ |
Ｊａｋ阻害剤の製造方法及びその中間体
|
|
KR20160045081A
(ko)
|
2013-08-07 |
2016-04-26 |
인사이트 코포레이션 |
Jak1 억제제용 지속 방출 복용 형태
|
|
US10463684B2
(en)
|
2014-01-29 |
2019-11-05 |
Board Of Regents, The Uneversety Of Texas System |
Nucleobase analogue derivatives and their applications
|
|
WO2015171516A1
(en)
|
2014-05-05 |
2015-11-12 |
Thetis Pharmaceuticals Llc |
Compositions and methods relating to ionic salts of peptides
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
US9242008B2
(en)
|
2014-06-18 |
2016-01-26 |
Thetis Pharmaceuticals Llc |
Mineral amino-acid complexes of fatty acids
|
|
BR112016029476A2
(pt)
|
2014-06-18 |
2017-08-22 |
Thetis Pharmaceuticals Llc |
complexos de aminoácido mineral de agentes ativos
|
|
CN104225615B
(zh)
*
|
2014-09-24 |
2017-02-01 |
东南大学 |
一种紫杉醇类磷脂化合物、其药物组合物及应用
|
|
WO2016198971A1
(en)
*
|
2015-06-08 |
2016-12-15 |
Mohan M Alapati |
Compositions and methods for the treatment of hyperglycemia and metabolic syndrome
|
|
CA3017367A1
(en)
*
|
2016-03-15 |
2017-09-21 |
Vitality Biopharma, Inc. |
Methods and compositions for the treatment of demyelinating disorders
|
|
JP6906047B2
(ja)
|
2016-06-03 |
2021-07-21 |
テティス・ファーマシューティカルズ・エルエルシー |
特異的炎症収束性メディエーターの塩に関連する組成物及び方法
|
|
WO2018002673A1
(en)
|
2016-07-01 |
2018-01-04 |
N4 Pharma Uk Limited |
Novel formulations of angiotensin ii receptor antagonists
|
|
RS66574B1
(sr)
|
2016-07-29 |
2025-03-31 |
Janssen Pharmaceutica Nv |
Niraparib za upotrebu u postupku lečenja raka prostate
|
|
EP3661937B1
(en)
|
2017-08-01 |
2021-07-28 |
Gilead Sciences, Inc. |
Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections
|
|
WO2019113487A1
(en)
|
2017-12-08 |
2019-06-13 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
CN112105608B
(zh)
|
2018-01-30 |
2023-07-14 |
因赛特公司 |
制备(1-(3-氟-2-(三氟甲基)异烟碱基)哌啶-4-酮)的方法
|
|
SMT202400306T1
(it)
|
2018-03-30 |
2024-09-16 |
Incyte Corp |
Trattamento dell'idrosadenite suppurativa utilizzando inibitori di jak.
|
|
WO2019204298A1
(en)
*
|
2018-04-17 |
2019-10-24 |
Cardurion Pharmaceuticals, Llc |
Meglumine salts of thienopyrimidines
|
|
WO2020018700A1
(en)
|
2018-07-18 |
2020-01-23 |
Manzanita Pharmaceuticals, Inc. |
Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
|
|
US11643438B2
(en)
|
2018-07-20 |
2023-05-09 |
The Board Of Regents Of The University Of Oklahoma |
Antimicrobial peptides and methods of use
|
|
MX2021000977A
(es)
|
2018-07-26 |
2021-04-12 |
Sumitomo Pharma Oncology Inc |
Metodos para tratar enfermedades asociadas con expresion anormal de receptor de activina a tipo 1 (acvr1) e inhibidores de acvr1 para uso en los mismos.
|
|
JP7610208B2
(ja)
*
|
2019-03-22 |
2025-01-08 |
インテグレイテッド ナノセラピューティクス インコーポレイテッド |
足場部分から調製した脂質結合体
|
|
KR20220107213A
(ko)
|
2019-11-22 |
2022-08-02 |
인사이트 코포레이션 |
Alk2 억제제 및 jak2 억제제를 포함하는 병용 요법
|
|
TW202139981A
(zh)
|
2020-01-22 |
2021-11-01 |
美商西羅斯醫療公司 |
降低nmda拮抗劑之副作用
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
CN119606959A
(zh)
*
|
2024-12-26 |
2025-03-14 |
典晶医药(无锡)有限公司 |
Tazofelone与紫杉类药物的组合物在治疗实体瘤中的应用
|